U 787 (Glipizide and Metformin 2.5 mg / 250 mg)
Pill imprint U 787 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for U 787 (Glipizide and Metformin 2.5 mg / 250 mg)
- 2.5 mg / 250 mg
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- USV Limited
- National Drug Code (NDC):
- Inactive Ingredients:
- sodium starch glycolate type A potato
hypromellose 2910 (15 mPa.s)
polyethylene glycol 6000
ferric oxide red
Glipizide and metformin hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...